Evercore ISI Group Maintains Outperform on Boston Scientific, Lowers Price Target to $78

Benzinga Newsdesk www.benzinga.com Negative 94.6%

Neg 94.6% Neu 0% Pos 0%

Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $80 to $78.